Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Dihydropteridinone derivatives, preparation method and use thereof

A kind of technology of tetrahydropyridine and piperidine, applied in the field of medicine

Active Publication Date: 2021-01-05
SICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] Since TLR7 agonists mainly play an immune antiviral role by stimulating and regulating the response of endogenous type I interferon (INF-α / β), increasing the expression of interferon downstream signaling interferon regulatory genes (ISGs), etc., TLR7 The mechanism of action of the agonist is to activate the autoimmune system to resist the virus, and it has no selective inhibition on different genotypes of hepatitis B

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Dihydropteridinone derivatives, preparation method and use thereof
  • Dihydropteridinone derivatives, preparation method and use thereof
  • Dihydropteridinone derivatives, preparation method and use thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation example 1

[0312] Preparation 1: N-(6-amino-2-methylsulfonyl-5-nitropyrimidin-4-yl)-N-(3-(pyrrolidine-1-methyl)benzyl)glycine ethyl ester (intermediate Preparation of body 1)

[0313]

[0314] The first step: the preparation of 3-(pyrrolidine-1-methyl)benzonitrile

[0315] 3-cyanobenzaldehyde (60g, 0.458mol) was added to a three-necked flask, THF (500mL) was added to dissolve, pyrrole and acetic acid were added; ice-water bath was cooled, and NaBH(OAc) was added 3 (145g, 0.687mol), after addition, slowly rise to room temperature and stir overnight (about 20 hours); TLC detects that the reaction is complete, the reaction solution is added to 1.5L water, and NaHCO 3 Solution Adjust the pH value of the aqueous solution to 8-9; add EA (500mL×1, 300mL×2) to extract the aqueous layer, combine the EA, wash with saturated brine, and dry over anhydrous sodium sulfate. Concentration of EA gave the title compound (62 g, yield 73%).

[0316] The second step: the preparation of 3-(pyrrolidine-1...

preparation example 2

[0324]Preparation Example 2: Preparation of 3-(4-amino-2-butoxy-6-oxo-6,7-dihydropteridin-8(5H)-yl)methyl-benzaldehyde (Intermediate 2) :

[0325]

[0326] The first step of preparation of N-(3-cyanobenzyl) glycine ethyl ester

[0327] Add m-cyanobenzaldehyde (80g, 0.61mol) and glycine ethyl ester hydrochloride (94g, 0.67mol) into a 2L three-necked flask, add 1.2L methanol, triethylamine and NaBH 3 CN, stirred at room temperature for 6 hours; TLC detected that the reaction was complete, added 4L of water and EA (1L x 1, 500mL x 2) to the reaction solution to extract the aqueous layer, combined EA, washed with saturated brine, and dried over anhydrous sodium sulfate. Concentration of EA yielded 112 g of the product with a yield of 84%.

[0328] The second step: the preparation of N-(6-amino-2-methylthio-5-nitropyrimidin-4-yl)-N-(3-cyanobenzyl)glycine ethyl ester

[0329] Add (3-cyanobenzyl)glycine ethyl ester and 6-amino-5-nitro-2-methylthio-4-chloropyrimidine into a 2L t...

preparation example 3

[0338] Preparation Example 3: Preparation of 6-chloro-2-methylthio-5-nitropyrimidin-4-amine (Intermediate 3)

[0339]

[0340] The raw material 5-nitro-2-methylthio-4,6-dichloropyrimidine (120g, 0.5mol) was added into a three-necked flask and dissolved in 600mL THF, then triethylamine and ammonia methanol (86mL, 0.6mol) were added, and the The reaction was stirred for 1 hour; TLC detected that the reaction was complete, and the reaction solution was added to 2L of water, filtered with suction, and the filter cake was successively washed with purified water (500mL×2) and petroleum ether (400mL) and dried to obtain 95g of the target product, with a yield of 86%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Disclosed are a dihydro pteridinone derivative represented by formula I, a pharmaceutically acceptable salt, ester, solvate, hydrate, isomer, and isotope compound thereof, any polymorphism or racemate thereof, or a metabolite form thereof, and a mixture thereof. Also disclosed are a preparation method for the dihydro pteridinone derivative, and an application in preparation of drugs for treating diseases related to TLR7.

Description

technical field [0001] The invention belongs to the field of medicine and relates to a TLR7 agonist, in particular to a dihydropteridone derivative, a preparation method and an application thereof. Background technique [0002] Toll-like receptors (Toll-like receptors, TLR) are an important class of proteins involved in nonspecific immunity (innate immunity), and are also a bridge connecting nonspecific immunity and specific immunity. TLR is a single transmembrane non-catalytic protein, belonging to the pattern recognition receptor (Pattern recognition receptor, PRR) family, which can quickly respond to pathogens. As one of the TLRs family, TLR7 is mainly expressed in lung, placenta, heart, bone marrow, lymph nodes and other tissues; the cells expressing TLR7 are mainly immune cells, including plasma-like dendritic cells (pDCs), myeloid dendritic cells (mDCs) ), B lymphocytes, macrophages, etc. (especially dendritic cells). TLR7 is mainly activated by viral single-stranded...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D475/06C07D475/08A61K31/519A61P31/12A61P35/00
CPCA61K31/519A61P31/12A61P35/00C07D475/06C07D475/08Y02A50/30
Inventor 刘钢于华陈强强康熙伟罗小勇蒋语涵曾宏宋宏梅刘瑞红王利春王晶翼
Owner SICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products